Metraipolis › archive › dc_49f95992153a

AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach — Europe PMC PMID:41617787

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41617787
DOI
10.1038/s41698-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-06T10:05:43.301Z
SHA-256 of the archived text
c18a4dda69c2a3f41d5af8384260f971b78c91c37a4247560f775513e37e79c4
Stable URL of this page
https://metraipolis.com/documento/dc_49f95992153a

How to cite

AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach — Europe PMC PMID:41617787 — Europe PMC (en), https://europepmc.org/article/MED/41617787 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49f95992153a (Metraipolis archive dc_49f95992153a, sha256 c18a4dda69c2a3f41d5af8384260f971b78c91c37a4247560f775513e37e79c4)
BibTeX
@misc{dc49f95992153a,
  title = {AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach — Europe PMC PMID:41617787},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41617787},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49f95992153a; sha256 c18a4dda69c2a3f41d5af8384260f971b78c91c37a4247560f775513e37e79c4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41617787. Agents can read the archived copy with the MCP tool read_document.